Long-term outcomes of intestinal transplantation
- PMID: 33651001
- DOI: 10.1097/MOT.0000000000000855
Long-term outcomes of intestinal transplantation
Abstract
Purpose of review: In this article, data from the intestinal transplant registry, recent publications and reviews in the field will be used to describe mortality, morbidity, complications, nutritional and psychosocial outcomes in intestinal transplant recipients with a focus on those furthest out from transplant.
Recent findings: Registry data show static long-term survival data (41% 10-year survival in the most recent analysis), but experienced centres report improvements with survival between 60 and 70% at 10 years. Chronic rejection remains a problem for long-term graft survival, but understanding of humoral immunity is increasing. Nutritional outcomes are good with most recipients achieving enteral autonomy with an unrestricted diet. Health-related quality of life data generally shows improvement in the years after transplant, educational attainment is good, but some patients have ongoing psychosocial problems.
Summary: Most patients do well in the long-term after transplant. Survival outcomes have improved in experienced centres, and nutrition and quality of life outcomes are good. Recognition of psychosocial outcomes is increasing. Nevertheless, challenges remain in areas such as infectious complications, renal function, chronic rejection, social support and mental health.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Starzl TE, Rowe MI, Todo S, et al. Transplantation of multiple abdominal viscera. J Am Med Assoc 1989; 261:1449–1457.
-
- Fishbein TM. Intestinal transplantation. N Engl J Med 2009; 361:998–1008.
-
- Grant D, Abu-Elmagd K, Mazareigos G, et al. Intestinal transplant registry report: global activity and trends. Am J Transplant 2015; 15:210–219.
-
- Farmer DG, Venick RS, Colangelo J, et al. Pretransplant predictors of survival after intestinal transplantation: analysis of a single-center experience of more than 100 transplants. Transplantation 2010; 90:1574–1580.
-
- Ceulemans L, Braza F, Monbaliu D, et al. The Leuven immunomodulatory protocol promotes T-regulatory cells and substantially prolongs survival after first intestinal transplantation. Am J Transplant 2016; 16:2973–2985.